Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
27.65%
Operating Margin
12.71%
Net Margin
3.60%
Efficiency Metrics
Revenue per Expense Ratio
1.14
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
22.16%
Income Tax Rate
26.39%
EPS
0.4400000000
Balance Sheet Analysis
Current Ratio
2.28
Cash Ratio
1.02
Working Capital
$943.00M
Debt to Equity
1.24
Debt to Assets
50.04%
Equity Ratio
40.49%
Cash Flow Analysis
Operating Cash Flow Ratio
19.20%
Free Cash Flow Ratio
8.64%
CapEx to Revenue
10.56%
Dividends Paid
$152.00M
Stock Buybacks
$180.00M
Total Shareholder Returns
$332.00M
Cash Position Change
-20.13%
Key Takeaways (2023 FY)
Increased dividend payments by 2,213.48%
Detailed Growth Metrics
Core Performance
Revenue
7.88%
Net Income
-40.12%
EPS
-38.03%
Operating Income
-16.95%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
3.17%
Operating Cash Flow
22.98%
Free Cash Flow
-9.54%
Balance Sheet Health
Assets
-3.21%
Debt
-2.84%
Book Value per Share
-6.44%
Inventory
0.00%
Shareholder Returns
Dividends per Share
2,213.48%
Shares Outstanding
-6.14%
Long Term Trends
3Y Revenue/Share
249.22%
5Y Revenue/Share
-6.49%
3Y Dividend/Share
-30.45%
5Y Dividend/Share
-68.93%